
    
      This study consists of a treatment phase (6 months) and a follow-up phase (6 month ).
      Eligible subjects will be randomly assigned to receive treatment with the study medication or
      placebo. Subjects will visit the clinic at 3, 6, and 12 months after treatment start for
      safety and efficacy evaluations.

      HCap Formula or placebo tablets will be taken orally every other day during 6 months.
    
  